Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies Before and After Chemotherapy-Reference-Cited by-同舟云学术

Influence of Age and the Gleason Score in the Choice of Novel Hormonal Therapies Before and After Chemotherapy

Published:2019-04 Issue:3 Volume:34 Page:141-146
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Roviello Giandomenico¹,Corona Silvia Paola²,Aieta Michele³,Roudi Raheleh⁴

Affiliation:

1. Division of Medical Oncology, Department of Onco-Hematology, IRCCS-CROB, Referral Cancer Center of Basilicata, Vulture, Italy.

2. Radiation Oncology Department, Peter MacCallum Cancer Centre, East Bentleigh, Victoria, Australia.

3. Department of Medical, Surgery and Health Sciences, University of Trieste, Trieste, Italy.

4. Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2018.2702

Reference15 articles.

1. Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

2. Abiraterone and Increased Survival in Metastatic Prostate Cancer

3. Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

4. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

5. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design;Trials;2021-09-16

2. Genome‐wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients;Cancer Medicine;2020-07-06